Search by Drug Name or NDC

    NDC 00456-3414-33 Namenda 14 mg/1 Details

    Namenda 14 mg/1

    Namenda is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is MEMANTINE HYDROCHLORIDE.

    Product Information

    NDC 00456-3414
    Product ID 0456-3414_ba05f457-602d-4eff-8897-0358c50202d2
    Associated GPIs 62053550107030
    GCN Sequence Number 070868
    GCN Sequence Number Description memantine HCl CAP SPR 24 14 MG ORAL
    HIC3 H1A
    HIC3 Description ALZHEIMER'S THERAPY, NMDA RECEPTOR ANTAGONISTS
    GCN 34525
    HICL Sequence Number 013778
    HICL Sequence Number Description MEMANTINE HCL
    Brand/Generic Brand
    Proprietary Name Namenda
    Proprietary Name Suffix XR
    Non-Proprietary Name memantine hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 14
    Active Ingredient Units mg/1
    Substance Name MEMANTINE HYDROCHLORIDE
    Labeler Name Allergan, Inc.
    Pharmaceutical Class N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022525
    Listing Certified Through 2024-12-31

    Package

    NDC 00456-3414-33 (00456341433)

    NDC Package Code 0456-3414-33
    Billing NDC 00456341433
    Package 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0456-3414-33)
    Marketing Start Date 2011-10-31
    NDC Exclude Flag N
    Pricing Information N/A